Abstract
Recently, we found nonsense and missense mutations of the PPP1R3 (protein phosphatase 1, regulatory subunit 3) gene in diverse human cancer cell lines and primary lung carcinomas, indicating that PPP1R3 functions as a tumor suppressor in human carcinogenesis. In this study, to assess the prevalence of PPP1R3 mutations in human primary cancers and the genetic diversity of the PPP1R3 gene in the human population, somatic mutations and genetic polymorphisms in the PPP1R3 gene were examined in 137 pairs of cancerous and non-cancerous tissues of patients with cancers of colon, ovary, and liver. Five somatic mutations including two missense mutations were detected in three cancerous tissues consisting of two colorectal carcinomas and one ovarian carcinoma. Five novel single nucleotide polymorphisms (SNPs) associated with the substitution of amino acids were also identified in cancer patients, in addition to five known nonsynonymous SNPs, including three previously reported ones as having an impact on the susceptibility to insulin resistant disorders. Differences in the activities and properties of multiple PPP1R3 proteins, which are produced in human cells due to variable somatic mutations and genetic polymorphisms in the PPP1R3 gene, can be involved in human carcinogenesis and susceptibility to diseases.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Chen YH, Hansen L, Chen MX, Bjorbaek C, Vestergaard H, Hansen T, Cohen PT and Pedersen O. . 1994 Diabetes 43: 1234–1241.
Cho KR, Oliner JD, Simons JW, Hedrick L, Fearon ER, Preisinger AC, Hedge P, Silverman GA and Vogelstein B. . 1994 Genomics 19: 523–531.
Egloff MP, Johnson DF, Moorhead G, Cohen PT, Cohen P and Barford D. . 1997 EMBO J. 16: 1876–1887.
Eng C. . 1998 Int. J. Oncol. 12: 701–710.
Faux MC and Scott JD. . 1996 Trends Biochem. Sci. 21: 312–315.
Fujiki H and Suganuma H. . 1993 Adv. Cancer Res. 61: 143–194.
Hansen L, Hansen T, Vestergaard H, Bjorbaek C, Echwald SM, Clausen JO, Chen YH, Chen MX, Cohen PT and Pedersen O. . 1995 Hum. Mol. Genet. 4: 1313–1320.
Isacchi A, Sarmientos P, Lorenzetti R and Soria M. . 1989 Gene 81: 129–137.
Kawabe T, Muslin AJ and Korsmeyer SJ. . 1997 Nature 385: 454–458.
Kohno T, Takahashi M, Manda R and Yokota J. . 1998a Genes Chromosome Cancer 22: 152–156.
Kohno T, Takahashi M, Fukutomi T, Ushio K and Yokota J. . 1998b Jpn. J. Cancer Res. 89: 471–474.
Kohno T, Takakura S, Yamada T, Okamoto A, Tanaka T and Yokota J. . 1999 Cancer Res. 59: 4170–4174.
Koike M, Takeuchi S, Yokota J, Park S, Hatta Y, Miller CW, Tsuruoka N and Koeffler HP. . 1997 Genes Chromosomes Cancer 19: 1–5.
Kukita Y, Tahira T, Sommer SS and Hayashi K. . 1997 Hum. Mutat. 10: 400–407.
Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittmann M, Tycko B, Hibshoosh H, Wigler MH and Parsons R. . 1997 Science 275: 1943–1947.
Liang H, Fairman J, Claxton DF, Nowell PC, Green ED and Nagarajan L. . 1998 Proc. Natl. Acad. Sci. USA 95: 3781–3785.
Liaw D, Marsh DJ, Li J, Dahia PL, Wang SI, Zheng Z, Bose S, Call KM, Tsou HC, Peacocke M, Eng C and Parsons R. . 1997 Nat. Genet. 16: 64–67.
Mermoud JE, Cohen PT and Lamond AI. . 1994 EMBO J. 13: 5679–5688.
Milland J, Christiansen D, Thorley BR, McKenzie IF and Loveland BE. . 1996 Eur. J. Biochem. 238: 221–230.
Nelen MR, van Staveren WC, Peeters EA, Hassel MB, Gorlin RJ, Hamm H, Lindboe CF, Fryns JP, Sijmons RH, Woods DG, Mariman EC, Padberg GW and Kremer H. . 1997 Hum. Mol. Genet. 6: 1383–1387.
Parsons R. . 1998 Curr. Opin. Oncol. 10: 88–91.
Rubin E, Tamrakar S and Ludlow JW. . 1998 Front. Biosci. 3: D1209–D1219.
Sakamoto H, Mori M, Taira M, Yoshida T, Matsukawa S, Shimizu K, Sekiguchi M, Terada M and Sugimura T. . 1986 Proc. Natl. Acad. Sci. USA 83: 3997–4001.
Shiseki M, Kohno T, Adachi J, Okazaki T, Otsuka T, Mizoguchi H, Noguchi M, Hirohashi S and Yokota J. . 1996 Genes Chromosomes Cancer 17: 71–77.
Steck PA, Pershouse MA, Jasser SA, Yung WK, Lin H, Ligon AH, Langford LA, Baumgard ML, Hattier T, Davis T, Frye C, Hu R, Swedlund B, Teng DH and Tavtigian SV. . 1997 Nat. Genet. 15: 356–362.
Strauss BS. . 1998 Semin. Cancer Biol. 8: 431–438.
Takenoshita S, Tani M, Mogi A, Nagashima M, Nagamachi Y, Bennett WP, Hagiwara K, Harris CC and Yokota J. . 1998 Carcinogenesis 19: 803–807.
Wang SS, Esplin ED, Li JL, Huang L, Gazdar A, Minna J and Evans GA. . 1998 Science 282: 284–287.
Xia J, Scherer SW, Cohen PT, Majer M, Xi T, Norman RA, Knowler WC, Bogardus C and Prochazka M. . 1998 Diabetes 47: 1519–1524.
Zenklusen JC, Thompson JC, Klein-Szanto AJ and Conti CJ. . 1995 Cancer Res. 55: 1347–1350.
Zenklusen JC, Weintraub LA and Green ED. . 1999 Neoplasia 1: 16–22.
Acknowledgements
This work was supported in part by a Grant-in-Aid from the Ministry of Health and Welfare for the 2nd-term Comprehensive 10-Year Strategy for Cancer Control, a Grant-in-Aid from the Ministry of Health and Welfare for Research on Human Genome and Gene Therapy, and Grants-in-Aid from the Ministry of Health and Welfare and from the Ministry of Education, Science, Sports and Culture of Japan. The authors thank staff members of National Cancer Center Hospital, Pathology Division of National Cancer Center Research Insititue, Obstetrics/Gynecology and Pathology Departments of the Jikei University School of Medicine, and 2nd Surgery Department of Gunma University School of Medicine for providing tumor specimens and pathological diagnosis. DLD-1, LoVo, HCT116, and HCT15 were provided by Dr M Perucho (La Jolla Cancer Research Center, Burnham Institute, CA, USA). A2780 was provided by Dr E Reed (National Cancer Institute, National Institutes of Health, Bethesda, MD, USA). SKOV3, SW626, and OV1063 were obtained from the American Type Culture Collection (ATCC). S Takakura and K Shimizu are recipients of the Research Resident Fellowship from the Foundation for Promotion of Cancer Research.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Takakura, S., Kohno, T., Shimizu, K. et al. Somatic mutations and genetic polymorphisms of the PPP1R3 gene in patients with several types of cancers. Oncogene 19, 836–840 (2000). https://doi.org/10.1038/sj.onc.1203388
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1203388
Keywords
This article is cited by
-
CE–MS-based urinary biomarkers to distinguish non-significant from significant prostate cancer
British Journal of Cancer (2019)
-
EPMA position paper in cancer: current overview and future perspectives
EPMA Journal (2015)
-
Molecular Screening of Cancer
Molecular Diagnosis & Therapy (2006)
-
Absence of PPP2R1A mutations in Wilms tumor
Oncogene (2001)